NASDAQ:MDVN - Medivation Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$81.44 0.00 (0.00 %)
(As of 12/10/2018 07:36 AM ET)
Previous Close$81.44
Today's Range$81.44 - $81.44
52-Week Range$26.41 - $81.48
VolumeN/A
Average Volume3.55 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medivation, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to treat serious diseases for which there are limited treatment options. The Company, in collaboration with Astellas Pharma, Inc. (Astellas), has one commercial product, XTANDI (enzalutamide) capsules (XTANDI). XTANDI has received marketing approval in the United States, Europe and other countries across the world for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and in Japan for the treatment of patients with castration-resistant prostate cancer (CRPC). The Company, in collaboration with Astellas, is also conducting investigational studies of enzalutamide in prostate cancer and in advanced breast cancer. It has developed a small molecule inhibitor of the sterol regulatory element-binding protein, or SREBP, pathway which it refers to as MDV4463.

Receive MDVN News and Ratings via Email

Sign-up to receive the latest news and ratings for MDVN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:MDVN
Previous Symbol
CUSIP58501N10
Phone+1-415-5433470

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees628
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Medivation (NASDAQ:MDVN) Frequently Asked Questions

What is Medivation's stock symbol?

Medivation trades on the NASDAQ under the ticker symbol "MDVN."

How were Medivation's earnings last quarter?

Medivation Inc (NASDAQ:MDVN) announced its quarterly earnings data on Tuesday, August, 9th. The biopharmaceutical company reported $0.29 EPS for the quarter, beating the Zacks' consensus estimate of $0.27 by $0.02. The biopharmaceutical company had revenue of $206 million for the quarter, compared to analysts' expectations of $214.52 million. The business's revenue for the quarter was up 17.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.58 earnings per share. View Medivation's Earnings History.

Has Medivation been receiving favorable news coverage?

Press coverage about MDVN stock has been trending very positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medivation earned a media sentiment score of 3.9 on InfoTrie's scale. They also assigned media coverage about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.

How do I buy shares of Medivation?

Shares of MDVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medivation's stock price today?

One share of MDVN stock can currently be purchased for approximately $81.44.

What is Medivation's official website?

The official website for Medivation is http://www.medivation.com/.

How can I contact Medivation?

Medivation's mailing address is 525 Market St Fl 36, SAN FRANCISCO, CA 94105-2747, United States. The biopharmaceutical company can be reached via phone at +1-415-5433470.


MarketBeat Community Rating for Medivation (NASDAQ MDVN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  672 (Vote Outperform)
Underperform Votes:  413 (Vote Underperform)
Total Votes:  1,085
MarketBeat's community ratings are surveys of what our community members think about Medivation and other stocks. Vote "Outperform" if you believe MDVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel